Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...

Cellarity, a clinical-stage, biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced acceptance of two oral presentations on ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

Posters will review product characterization and manufacturing data on T-knife’s lead program, TK-6302, a supercharged PRAME ...

The University of Maryland has received $51.7 million in new philanthropic investments from its most generous benefactor, the A. James & Alice B. Clark Foundation, to dramatically expand scholarships ...

Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company"), a leader in the development of differentiated targeted radiotherapies, announced today that new preclinical data for its lead antibody ...

Zinia Khattar, a Del Norte High graduate who is attending Harvard University, received a $50,000 scholarship as a Davidson ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...

Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...

In a groundbreaking study [1] published in Science, researchers from the Broad Institute of MIT and Harvard and collaborators unveiled the first high-resolution atlas of how enteric neurons adapt to ...